The growing demand for treatments using biological drugs has created a challenge for injectable devices to deliver high viscosity next-generation formulations all the while putting patient comfort and usability first. Building upon more than 10 years of experience with auto injectors for highly viscous drugs, SHL’s Rotaject® technology is the ultimate solution for this challenge.
This groundbreaking technology has been featured in the 2017 Spring edition of World Pharmaceutical Frontiers. To learn more about the Rotaject® technology, read the full article online .
SHL is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as auto injectors and pen injectors. With locations in Taiwan, Sweden and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of “next-generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
With over 3,700 staff worldwide, our organization consists of several distinct group companies:
SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe
SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products
For additional information visit www.shl.group